# reload+after+2024-01-21 22:44:16.108993
address1§505 South Friendswood Drive
address2§Suite 401
city§Friendswood
state§TX
zip§77546
country§United States
phone§866 788 9007
website§https://castlebiosciences.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary 35-GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
fullTimeEmployees§587
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Derek J. Maetzold', 'age': 61, 'title': 'Founder, CEO, President & Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1449675, 'exercisedValue': 203300, 'unexercisedValue': 3967912}, {'maxAge': 1, 'name': 'Mr. Frank  Stokes', 'age': 53, 'title': 'CFO & Treasurer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 849360, 'exercisedValue': 62360, 'unexercisedValue': 953334}, {'maxAge': 1, 'name': 'Ms. Kristen M. Oelschlager R.N.', 'age': 55, 'title': 'Chief Operating Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 782700, 'exercisedValue': 136741, 'unexercisedValue': 562755}, {'maxAge': 1, 'name': 'Mr. Tobin W. Juvenal', 'age': 63, 'title': 'Chief Commercial Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 782700, 'exercisedValue': 68945, 'unexercisedValue': 665486}, {'maxAge': 1, 'name': 'Camilla  Zuckero', 'title': 'Vice President of Investor Relations & Corporate Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Alice Bahner Izzo', 'title': 'Senior Vice President of Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin  Doman', 'title': 'Vice President of Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Keli  Greenberg', 'title': 'VP of Human Resources & Executive Director of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert W. Cook Ph.D.', 'age': 51, 'title': 'Senior Vice President of Research & Development', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Matthew  Goldberg M.D.', 'title': 'Senior Vice President of Medical', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§5
compensationRisk§10
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.971
priceToSalesTrailing12Months§2.943244
currency§USD
dateShortInterest§1702598400
forwardEps§-2.86
exchange§NGM
quoteType§EQUITY
shortName§Castle Biosciences, Inc.
longName§Castle Biosciences, Inc.
firstTradeDateEpochUtc§1564061400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§6b173df7-6adf-3e94-ab1e-751cd770e557
gmtOffSetMilliseconds§-18000000
targetHighPrice§37.0
targetLowPrice§25.0
targetMeanPrice§31.56
targetMedianPrice§32.0
recommendationMean§1.4
recommendationKey§strong_buy
numberOfAnalystOpinions§9
quickRatio§7.344
grossMargins§0.78085
ebitdaMargins§-0.38282
trailingPegRatio§None
